Choice of antithrombotics and long term outcome in stroke

Stroke is a very common condition. Stroke due to clotting of blood vessles (ischaemic stroke)
constitutes about 85% of all strokes in Western countries. Drugs that prevent clot formation are the
established long term treatment. These drugs either act on platelets or on factors that initiate
clotting. They are collectively known as antithrombotics. There are several types of these agents and
it is not known whether the choice of specific drug impacts the outcome in ischaemic stroke. This
project will use real world data collected through a large stroke registry to answer this research
question.